Dr. Ruben Amarasingham, Founder and CEO of PCCI
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Ruben Amarasingham, Founder and CEO of PCCI, a non-profit research and development corporation in Dallas, Texas that specializes in real-time predictive and surveillance analytics for health care. Dr. Amarasingham discusses the system he created that is significantly reducing hospital re-admissions and the potential for greatly improved health outcomes utilizing real time health data analytics.
This week on Conversations on Health Care, hosts Mark Masselli and Margaret Flinter speak with Jennifer Tolbert, Director of State Health Reform at the Kaiser Family Foundation. She breaks down the roll out of the Affordable Care Act and its potential impact on the uninsured population and how it may differ in states across the country.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Ardis Dee Hoven, President of the American Medical Association, the largest and oldest organization in the nation representing medical professionals. Dr. Hoven discusses the implementation of the Affordable Care Act and its impact on the future of the practice of medicine in this country.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. H. Jack Geiger, co-founder of Physicians for Human Rights and Physicians for Social Responsibility, both of which went on to earn the Nobel Prize for Peace. Dr. Geiger is considered the founder of the Community Health Center movement in this country and discusses his decades of activism for equality in health care.
Mark Masselli and Margaret Flinter speak with Dr. John Bartlett, Senior Project Advisor for the Primary Care Initiative at the Carter Center. Dr. Bartlett discusses the Carter Center’s efforts to better facilitate behavioral health and substance abuse treatment in the primary care setting.
This week, Mark and Margaret speak with futurist Dr. Clement Bezold, co-founder and Chairman of the Institute for Alternative Futures. Dr. Bezold outlines his report on the future of health care in America, based on long term analysis of the impact of technology, genomics and health industry reform.